A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Head and Neck Cancer · Cervical Cancer · Endometrial Cancer · Triple Negative Breast Cancer · Ovarian Cancer · Soft Tissue Sarcoma · Melanoma · Nasopharyngeal Carcinoma · Non Small Cell Lung Cancer · Classic Hodgkin Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shandong Cancer Hospital, Jinan, Shandong, China
Contact: Study coordinator (Sun yuping)
Study leads
Jin Li, M.D.
Principal Investigator
Shanghai East Hospital